Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.18B | 1.26B | 1.06B | 909.10M | 1.11B | 859.20M |
Gross Profit | 497.24M | 478.16M | 296.66M | 220.80M | 313.50M | 146.70M |
EBITDA | 505.92M | 543.56M | 378.19M | 303.84M | 411.31M | 275.73M |
Net Income | 354.39M | 359.15M | 173.49M | 107.08M | 210.50M | 37.08M |
Balance Sheet | ||||||
Total Assets | 3.35B | 3.47B | 3.65B | 3.79B | 3.64B | 3.73B |
Cash, Cash Equivalents and Short-Term Investments | 216.24M | 323.16M | 207.70M | 114.30M | 362.20M | 84.60M |
Total Debt | 1.06B | 1.19B | 1.45B | 1.60B | 1.46B | 1.46B |
Total Liabilities | 1.37B | 1.64B | 1.69B | 1.80B | 1.69B | 1.74B |
Stockholders Equity | 1.92B | 1.77B | 1.86B | 1.87B | 1.77B | 1.47B |
Cash Flow | ||||||
Free Cash Flow | 125.63M | 159.06M | 202.87M | -264.10M | 70.00M | 113.00M |
Operating Cash Flow | 209.29M | 261.59M | 298.38M | 269.20M | 325.10M | 204.20M |
Investing Cash Flow | 378.06M | 354.01M | 124.09M | -516.40M | -26.30M | -213.60M |
Financing Cash Flow | -404.27M | -479.36M | -328.87M | -4.60M | -16.30M | 27.00M |
On June 30, 2025, Rayonier Inc. announced the completion of the sale of its New Zealand business to an investment fund managed by The Rohatyn Group for $710 million. The net proceeds of $699 million are intended to reduce leverage, return capital to shareholders, and fund other capital allocation priorities. This transaction is part of Rayonier’s asset disposition and capital structure realignment plan, which has exceeded its original target, allowing the company to better position itself for long-term shareholder value.
The most recent analyst rating on (RYN) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Rayonier stock, see the RYN Stock Forecast page.
On May 15, 2025, Rayonier Inc. held its Annual Meeting of Shareholders, during which all nine director nominees were elected to terms expiring in 2026. Additionally, shareholders approved the compensation of the company’s named executive officers on a non-binding advisory basis and ratified the appointment of Ernst & Young, LLP as the independent registered public accounting firm for 2025.
The most recent analyst rating on (RYN) stock is a Hold with a $25.00 price target. To see the full list of analyst forecasts on Rayonier stock, see the RYN Stock Forecast page.